Finch Therapeutics Group, Inc.盘中异动大幅下挫21.72%

自选股智能写手05-24

北京时间2024年05月24日21时31分，Finch Therapeutics Group, Inc.（FNCH.us）股票出现异动，股价快速跳水21.72%。截至发稿，该股报1.55美元/股，成交量4.1639万股，换手率2.59%，振幅10.10%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.88百万美元，每股收益-2.41美元，毛利-43000.00美元，市盈率-0.16...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2437583930?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-05-24 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2437583930","market":"us","top_or_hot":-1,"title":"Finch Therapeutics Group, Inc.盘中异动 大幅下挫21.72%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年05月24日21时31分，Finch Therapeutics Group, Inc.（FNCH.us）股票出现异动，股价快速跳水21.72%。截至发稿，该股报1.55美元/股，成交量4.1639万股，换手率2.59%，振幅10.10%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.88百万美元，每股收益-2.41美元，毛利-43000.00美元，市盈率-0.16...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242131559ee31327&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Finch Therapeutics Group, Inc.盘中异动 大幅下挫21.72%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFinch Therapeutics Group, Inc.盘中异动 大幅下挫21.72%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-24 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242131559ee31327&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年05月24日21时31分，Finch Therapeutics Group, Inc.（FNCH.us）股票出现异动，股价快速跳水21.72%。截至发稿，该股报1.55美元/股，成交量4.1639万股，换手率2.59%，振幅10.10%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.88百万美元，每股收益-2.41美元，毛利-43000.00美元，市盈率-0.16...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242131559ee31327&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242131559ee31327&s=b","article_id":"2437583930","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242131559ee31327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2437583930","pubTimestamp":1716557515,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年05月24日21时31分，Finch Therapeutics Group, Inc.股票出现异动，股价快速跳水21.72%。Finch Therapeutics Group, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Merus N.V.、Biora Therapeutics, Inc.、Bioline Rx Ltd涨幅较大，Verastem, Inc.、Jaguar Health, Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为24.20%、7.24%、6.79%，振幅较大的相关个股有Kronos Bio, Inc.、Cognition Therapeutics, Inc.、Finch Therapeutics Group, Inc.，振幅分别为12.11%、10.77%、10.10%。Finch Therapeutics Group, Inc.公司简介：Finch Therapeutics Group Inc是一家微生物组技术公司，拥有知识产权和微生物组资产组合。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","FNCH":"Finch Therapeutics Group, Inc.","BK4139":"生物科技"},"translate_title":"Finch Therapeutics Group, Inc. fell 21.72% in intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FNCH":1,"LENZ":1},"content_text":"北京时间2024年05月24日21时31分，Finch Therapeutics Group, Inc.（FNCH.us）股票出现异动，股价快速跳水21.72%。截至发稿，该股报1.55美元/股，成交量4.1639万股，换手率2.59%，振幅10.10%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-3.88百万美元，每股收益-2.41美元，毛利-43000.00美元，市盈率-0.16倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Finch Therapeutics Group, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Merus N.V.、Biora Therapeutics, Inc.、Bioline Rx Ltd涨幅较大，Verastem, Inc.、Jaguar Health, Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为24.20%、7.24%、6.79%，振幅较大的相关个股有Kronos Bio, Inc.、Cognition Therapeutics, Inc.、Finch Therapeutics Group, Inc.，振幅分别为12.11%、10.77%、10.10%。Finch Therapeutics Group, Inc.公司简介：Finch Therapeutics Group Inc是一家微生物组技术公司，拥有知识产权和微生物组资产组合。Finch 拥有强大的知识产权，反映了该公司在微生物组治疗领域的先锋作用，其中包括 70 多项已发布的美国和外国专利，这些专利与一系列潜在适应症中的供体来源和非供体微生物组疗法至关重要。该公司的资产包括 CP101——一种口服微生物组候选药物，在复发性艰难梭菌感染 (CDI) 的 2 期随机、安慰剂对照试验和 2 期开放标签试验中具有积极的临床数据。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2437583930"}

Finch Therapeutics Group, Inc.盘中异动 大幅下挫21.72%

精彩评论

Finch Therapeutics Group, Inc.盘中异动大幅下挫21.72%